From: Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer
Complete response (CR)
Partial response (PR)
Stable disease (SD)
R-TP group
5 (17.9%)
15 (53.6%)
8 (28.3%)
R-FP group
5 (22.7%)
11 (50.0%)
6 (27.3 %)